Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules
Cancer Cytopathology · 2024-05 · 132 (5) · 309-319
DOI: 10.1002/cncy.22796 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Cytopathology, online erschienen am 06.02.2024. Verfasst von Samantha Peiling Yang und 27 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Division, Department of Medicine, National University Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Thyroid Nodule. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Endocrine and Metabolic Society of Singapore, National University Healthcare System Clinician Scientist Program.
Abstract (Originalsprache)
Background
Most thyroid nodules are benign. It is important to determine the likelihood of malignancy in such nodules to avoid unnecessary surgery. The primary objective of this study was to characterize the genetic landscape and the performance of a multigene genomic classifier in fine‐needle aspiration (FNA) biopsies of cytologically indeterminate thyroid nodules in a Southeast Asian cohort. The secondary objective was to assess the predictive contribution of clinical characteristics to thyroid malignancy.
Methods
This prospective, multicenter, blinded study included 132 patients with 134 nodules. Molecular testing (MT) with ThyroSeq v3 was performed on clinical or ex‐vivo FNA samples. Centralized pathology review also was performed.
Results
Of 134 nodules, consisting of 61% Bethesda category III, 20% category IV, and 19% category V cytology, and 56% were histologically malignant. ThyroSeq yielded negative results in 37.3% of all FNA samples and in 42% of Bethesda category III–IV cytology nodules. Most positive samples had RAS ‐like (41.7%), followed by BRAF ‐like (22.6%), and high‐risk (17.9%) alterations. Compared with North American patients, the authors observed a higher proportion of RAS ‐like mutations, specifically NRAS , in Bethesda categories III and IV and more BRAF ‐like mutations in Bethesda category III. The test had sensitivity, specificity, negative predictive value, and positive predictive value of 89.6%, 73.7%, 84.0%, and 82.1%, respectively. The risk of malignancy was predicted by positive MT and high‐suspicion ultrasound characteristics according to American Thyroid Association criteria.
Conclusions
Even in the current Southeast Asian cohort with nodules that had a high pretest cancer probability, MT could lead to potential avoidance of diagnostic surgery in 42% of patients with Bethesda category III–IV nodules. MT positivity was a stronger predictor of malignancy than clinical parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Division, Department of Medicine, National University Hospital, Singapore, Singapore.
- Endocrinology Division, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Pathology, National University Hospital, Singapore, Singapore.
- Department of Pathology, Tan Tock Seng Hospital, Singapore, Singapore.
- Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pathology, Changi General Hospital, Singapore, Singapore.
ORCID-Profile: Samantha Peiling Yang, Simion I Chiosea, Yuri E Nikiforov
Förderung
- Endocrine and Metabolic Society of Singapore
- National University Healthcare System Clinician Scientist Program
Zitieren
APA
Yang, S. P., Nga, M. E., Bundele, M. M., Chiosea, S. I., Tan, S. H., Lum, J. H. Y., Parameswaran, R., Lim, M. Y., Li, H., Cheah, W. K., Sek, K. S., Tan, A. T. H., Loh, T. K. S., Ngiam, K. Y., Tan, W. B., Huang, X., Ho, T. W. T., Lim, K. H., Lim, C. M., …, & Tai, E. S. (2024). Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules. Cancer Cytopathology, 132(5), 309-319. https://doi.org/10.1002/cncy.22796
Vancouver
Yang SP, Nga ME, Bundele MM, Chiosea SI, Tan SH, Lum JHY, et al. Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules. Cancer Cytopathology. 2024;132(5):309-319. doi:10.1002/cncy.22796
BibTeX
@article{Yang2024,
author = {Yang, Samantha Peiling and Nga, Min En and Bundele, Manish Mahadeorao and Chiosea, Simion I and Tan, Sze Hwa and Lum, Jeffrey H Y and Parameswaran, Rajeev and Lim, Ming Yann and Li, Hao and Cheah, Wei Keat and Sek, Kathleen Su-Yen and Tan, Andre Teck Huat and Loh, Thomas Kwok Seng and Ngiam, Kee Yuan and Tan, Wee Boon and Huang, Xinyong and Ho, Thomas Wai Thong and Lim, Keng Hua and Lim, Chwee Ming and Singaporewalla, Reyaz M and Rao, Anil Dinkar and Rao, Nandini C L and Chua, Dennis Yu Kim and Chin, David Chao-Wu and Wald, Abigail I and LiVolsi, Virginia A and Nikiforov, Yuri E and Tai, E Shyong},
title = {Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules},
journal = {Cancer Cytopathology},
year = {2024},
volume = {132},
number = {5},
pages = {309--319},
doi = {10.1002/cncy.22796}
}
EUVIMED